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Summary
Background Low haemoglobin concentrations and anaemia are important risk factors for the health and development 
of women and children. We estimated trends in the distributions of haemoglobin concentration and in the prevalence 
of anaemia and severe anaemia in young children and pregnant and non-pregnant women between 1995 and 2011.
Methods We obtained data about haemoglobin and anaemia for children aged 6–59 months and women of 
childbearing age (15–49 years) from 257 population-representative data sources from 107 countries worldwide. We 
used health, nutrition, and household surveys; summary statistics from WHO’s Vitamin and Mineral Nutrition 
Information System; and summary statistics reported by other national and international agencies. We used a 
Bayesian hierarchical mixture model to estimate haemoglobin distributions and systematically addressed missing 
data, non-linear time trends, and representativeness of data sources. We quantiﬁ ed the uncertainty of our estimates.
Findings Global mean haemoglobin improved slightly between 1995 and 2011, from 125 g/L (95% credibility interval 
123–126) to 126 g/L (124–128) in non-pregnant women, from 112 g/L (111–113) to 114 g/L (112–116) in pregnant 
women, and from 109 g/L (107–111) to 111 g/L (110–113) in children. Anaemia prevalence decreased from 33% (29–37) 
to 29% (24–35) in non-pregnant women, from 43% (39–47) to 38% (34–43) in pregnant women, and from 47% 
(43–51) to 43% (38–47) in children. These prevalences translated to 496 million (409–595 million) non-pregnant 
women, 32 million (28–36 million) pregnant women, and 273 million (242–304 million) children with anaemia in 
2011. In 2011, concentrations of mean haemoglobin were lowest and anaemia prevalence was highest in south Asia 
and central and west Africa.
Interpretation Children’s and women’s haemoglobin statuses improved in some regions where concentrations had 
been low in the 1990s, leading to a modest global increase in mean haemoglobin and a reduction in anaemia 
prevalence. Further improvements are needed in some regions, particularly south Asia and central and west Africa, to 
improve the health of women and children and achieve global targets for reducing anaemia.
Funding Bill & Melinda Gates Foundation, Grand Challenges Canada, and the UK Medical Research Council.
Introduction
Anaemia, or low concentrations of haemoglobin, 
adversely aﬀ ect cognitive and motor development and 
cause fatigue and low productivity.1–3 Low haemoglobin 
concentrations during pregnancy can be associated 
with an increased risk of maternal and perinatal 
mortality and low size or weight at birth.2,4–6 Maternal 
and neonatal deaths are a major cause of mortality in 
developing countries, and together cause between 
2·5 million and 3·4 million deaths worldwide.7–9 
Although some adverse eﬀ ects are associated with high 
haemoglobin concentrations,10 most take place along a 
continuum of low concentrations, with each decrement 
associated with worse outcomes. Other eﬀ ects might be 
restricted to concentrations that correspond to 
moderate-to-severe anaemia.2,4
Awareness about anaemia and its consequences for the 
health and development of women and children has 
increased in the past few decades. In 2012, the 65th World 
Health Assembly approved an action plan and global 
targets for maternal, infant, and child nutrition, with a 
commitment to halve anaemia prevalence in women of 
reproductive age by 2025, from 2011 levels. As such, 
attention to nutritional interventions, such as the Scaling 
Up Nutrition initiative, has increased. Furthermore, 
emphasis has been placed on the reduction of risk factors 
that adversely aﬀ ect women and children, for example in 
the UN Secretary-General’s Every Woman Every Child 
initiative and the accompanying Global Strategy for 
Women’s and Children’s Health. To plan for these 
programmes and prioritise interventions, information is 
needed about haemoglobin and anaemia in women and 
Lancet Glob Health 2013; 
1: e16–25
See Comment page e4
Copyright © Stevens et al. Open 
Access article distributed under 
the terms of CC BY
*Members listed at the end of 
the report
Department of Health 
Statistics and Information 
Systems (G A Stevens DSc) and 
Department of Nutrition for 
Health and Development 
(L M De-Regil DrSc, 
F Branca  PhD, 
J P Peña-Rosas MD), WHO, 
Geneva, Switzerland; 
Gladstone Institutes, 
University of California, 
San Francisco, CA, USA 
(M M Finucane PhD); 
Department of Statistics, 
University of California, 
Berkeley, CA, USA 
(C J Paciorek PhD); School of 
Computer Science and Heinz 
College, Carnegie Mellon 
University, Pittsburgh, PA, USA 
(S R Flaxman BA); Division of 
Women and Child Health, Aga 
Khan University, Karachi, 
Pakistan (Prof Z A Bhutta PhD); 
and Department of 
Epidemiology and 
Biostatistics, MRC-HPA Centre 
for Environment and Health, 
Imperial College London, 
London, UK (Prof M Ezzati PhD)
Correspondence to:
Prof Majid Ezzati, MRC-HPA 
Centre for Environment and 
Health, Department of 
Epidemiology and Biostatistics, 
Imperial College London, London 
W2 1PG, UK
majid.ezzati@imperial.ac.uk
Articles
e17 www.thelancet.com/lancetgh    Vol 1   July 2013
children, and how they have changed over time. We 
aimed to estimate trends in the complete distributions of 
haemoglobin concentration and anaemia prevalence by 
severity for young children and pregnant and non-
pregnant women by country and region.
Methods 
Study design
We estimated 1995–2011 trends in distributions of 
haemoglobin concentration for children aged 6–59 months 
and for women of reproductive age (15–49 years), by 
pregnancy status, in 190 countries and territories 
organised into 11 regions (appendix p 10). Our analysis 
comprised three steps: (1) identifying data sources, 
accessing and extracting data, and systematically assessing 
population representativeness of data; (2) adjusting 
haemoglobin for altitude; and (3) applying a statistical 
model to estimate trends in haemoglobin distributions 
and their uncertainties. The distributions estimated in the 
third step provide coherent and consistent estimates of 
mean haemoglobin and of the prevalences of total and 
severe anaemia. We deﬁ ned total anaemia on the basis of 
WHO cutoﬀ  points of haemoglobin less than 110 g/L for 
children younger than 5 years and pregnant women, and 
less than 120 g/L for non-pregnant women.11 We deﬁ ned 
severe anaemia as haemoglobin less than 70 g/L for 
children younger than 5 years and pregnant women, and 
less than 80 g/L for non-pregnant women.11 Because we 
estimated full distributions, prevalences based on other 
cutoﬀ s (eg, <80 g/L, which is used as an indicator of 
malaria burden in children12) can be calculated and are 
available from the investigators by request.
Data sources
We designed our data search and access strategy to obtain 
as many sources as possible while ensuring that the 
sources were representative of the population at the 
national level, or at least covered three regions within the 
country. To estimate complete distributions without 
overly restrictive assumptions, we accessed as many 
sources as possible with data available for individual 
participants. The appendix (pp 1–3) provides details of 
our data search and access and our inclusion criteria. In 
brief, our data sources were health examination, nutrition, 
and household surveys with anonymised individual 
records available through national and international 
agencies and survey databases; summary statistics, 
including mean haemoglobin concentration and anaemia 
prevalence, from WHO’s Vitamin and Mineral Nutrition 
Information System; and summary statistics not in the 
WHO database, which were provided or reported by other 
national and international agencies.
Our statistical model used stratiﬁ ed data for pregnant 
and non-pregnant women when available, and accounted 
for the proportion of women who were pregnant from 
sources that reported combined summaries for both 
groups of women. Reporting of pregnancy status in 
household surveys tends to become consistent only after 
about week 6–10 of pregnancy. This period is also about 
the same as that during which the decline in haemoglobin 
concentrations of pregnant women was steepest 
(appendix p 21). To be consistent with reporting 
behaviours and to restrict pregnancy to periods when 
haemoglobin concentrations are consistently low, we 
limited our operational deﬁ nition of pregnancy to after 8 
weeks of gestation (appendix p 4).
Adjustment of haemoglobin for altitude and smoking
Physiological haemoglobin needs are greater at high 
altitude because of the lower concentration of oxygen in 
the atmosphere, and smoking increases haemoglobin 
concentrations.11,13 To depict the health and functional 
consequences of low haemoglobin in a comparable way, 
haemoglobin concentrations of people living more than 
1000 m above sea level should be adjusted downwards to 
avoid underestimation of anaemia prevalence. Some 
sources provided data that had been adjusted for altitude 
with a formula from the US Centers for Disease Control 
and Prevention (CDC; appendix p 5).13 For data sources 
that had not been adjusted at the time of access, when 
individual-level data included information about the 
altitude of residence, we adjusted for altitude with use of 
the CDC formula. When individual-level data did not 
contain information about the altitude of residence or 
when data were available as summary statistics only, we 
used the data without adjustment in 144 countries where 
5% or fewer of the population lived at elevations of 
1500 m or higher (altitudes that correspond to at least a 
3 g/L eﬀ ect on mean haemoglobin). For 11 data sources 
from countries where more than 5% of people lived at 
high altitudes, we adjusted summarised data sources for 
altitude (appendix p 5). We used data adjusted for 
smoking status if available (eg, for all Demographic and 
Health Surveys [DHS]), but made no post-adjustment to 
data that were not adjusted for smoking status because 
the eﬀ ects of smoking (a roughly 0·3 g/L eﬀ ect) are 
substantially smaller than are those of altitude (roughly 
8 g/L for those living above 2000 m).
Modelling of trends in haemoglobin distributions
We aimed to estimate the complete distributions of 
haemoglobin for every country and year, which would 
then allow us to calculate any relevant summary statistic. 
We did all analyses separately for children and women of 
reproductive age. We pooled data from boys and girls 
because their mean haemoglobin concentrations tracked 
closely (appendix p 22) and because some sources did not 
separate data by sex.
As described in detail elsewhere,14 we used a Bayesian 
hierarchical mixture model, in which estimates made for 
each country-year were informed by data from that 
country-year itself, if available, and by data from other 
years in the same country and in other countries, especially 
those in the same region with data for similar time periods 
See Online for appendix
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(appendix pp 7–8). The hierarchical model borrows 
information to a greater extent when data are non-existent 
or weakly informative (ie, have large uncertainty), and to a 
lesser degree in data-rich countries and regions. We 
modelled trends over time as a linear trend plus a smooth 
non-linear trend, at national, regional, and global levels. 
The estimates are also informed by covariates that help 
predict haemoglobin concentrations, including maternal 
education,15 proportion of population in urban areas, mean 
latitude, prevalence of sickle-cell disorders and 
thalassaemias,16 mean body-mass index (BMI)17 for women, 
and mean weight-for-age Z score14 for children. All 
covariates were available for every country and year, except 
the prevalences of sickle-cell disorders and thalassaemias, 
which we treated as constant over time during the analysis 
period for each country. The model included a variance 
term that accounted for unobserved design factors (eg, 
sample design, season, method of haemoglobin measure-
ment), which led to additional variability in the data beyond 
that expected because of sample size. Finally, the model 
accounted for the fact that subnational data and data that 
did not precisely cover the age ranges of interest might 
have had larger variations than did national data and data 
that did cover those ranges. We ﬁ tted the model to data 
from 1990 to 2012 to restrict boundary eﬀ ects, but results 
are reported for 1995–2011, because very few sources were 
available between 1990 and 1995, and in 2012.
The model uses a mixture (ie, a weighted-average) of 
various normal (bell-shaped) densities to estimate the full 
haemoglobin distributions, which might themselves be 
skewed. We used a mixture of ﬁ ve normal distributions for 
children. For adult women, we used two ﬁ ve-component 
mixtures, one for pregnant women and one for non-
pregnant women. This approach used all data sources—ie, 
those that separate pregnant and non-pregnant women, 
those in which pregnant and non-pregnant women are 
reported together, and those in which only one group was 
measured—to make separate estimates by pregnancy 
status. Diﬀ erences in haemoglobin distributions between 
pregnant and non-pregnant women could vary by country 
and year. In years and countries for which separate data by 
pregnancy status were scarce, the diﬀ erence was informed 
on the basis of other sources, especially those in the same 
region with data for similar time periods.
The uncertainties of our estimates incorporated 
sampling error in each data source; non-sampling error 
(eg, because of issues in sample design and measure-
ment); additional error associated with subnational data; 
uncertainty due to altitude adjustments; and uncertainty 
due to estimates being made by country and year when 
data were missing, when only summary statistics (vs 
individual-level data) were available, or when data were 
not available separately by pregnancy status.
We ﬁ tted the Bayesian model with the Markov chain 
Monte Carlo (MCMC) algorithm and obtained 
2500 samples from the parameters’ posterior, which we 
used to obtain 2500 posterior samples of the population 
haemoglobin distributions for each country-year. We 
used the distributions to calculate the population 
haemoglobin mean and total and severe anaemia 
prevalence for each country-year. The credibility intervals 
represent the 2·5th–97·5th centiles of these sampled 
distributions. We calculated distributions for regions and 
the world as population-weighted averages of the 
constituent countries. We calculated average changes in 
mean haemoglobin or anaemia prevalence over the 
16 years of reporting (absolute for mean and proportional 
for prevalence), and report ﬁ ndings as change per decade. 
We report the posterior probability that an estimated 
increase or decrease represents a truly increasing or 
decreasing trend. The posterior probability would be 0·50 
when an increase is statistically indistinguishable from a 
decrease, and a larger probability shows more certainty.
Role of the funding source
The sponsors of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The Writing and Global Analysis Group had 
123 health examination surveys with
individual-level data available to authors
1091 data sources included in WHO’s 
VMNIS
997 data sources excluded
270 were from before 1990
192 were not representative of populations 
of countries or large regions
82 because individual-level data were 
obtained or data were duplicated
371 used a school, clinic, or facility-based 
sampling method
57 were from selected subgroups that could 
have lower or higher nutritional and 
health status than the general population 
(eg, refugees), because a non-random 
sampling method was used, or because 
sampling methods were not adequately 
described
4 were from rural areas
1 because covariate data were not available 
for the country
3 because anaemia was not deﬁned based 
on haemoglobin
7 because they only reported data that 
included men, children aged 5–15 years, 
or elderly women
10 because they were from high-altitude 
countries but had not reported whether 
haemoglobin values were adjusted 
for altitude
40 data sources from country reports 
(including from preliminary DHS 
and MIS reports)
Data as summary statistics for 
134 data sources
257 data sources extracted
205 for children
224 for women
Figure 1: Flowchart of data identiﬁ cation, access, and extraction
VMNIS=Vitamin and Mineral Nutrition Information System. DHS=Demographic and Health Surveys. MIS=Malaria 
Indicator Surveys.
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access to all data sources. The corresponding author is 
responsible for the content of the report and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Our ﬁ nal dataset included 257 surveys, comprising 
232 (90%) nationally representative sources, with 
1·9 million haemoglobin measurements (ﬁ gure 1, 
appendix pp 11–20 and 23, 24). 205 (80%) sources had 
data for women (providing an average of 1·1 years of data 
per country or territory) and 224 (87%) had data for 
children (1·2 years of data per country or territory). Of 
190 countries, 107 (56%), covering 85% of the global 
population of women and children, had at least one data 
source; 71 (37%) had at least two sources. Data were most 
sparse in high-income regions and in central and eastern 
Europe, with 43 sources in ten (20%) of 50 countries. By 
contrast, all countries in south Asia had at least one data 
1995 2011
Mean haemoglobin (g/L) Anaemia (%) Severe anaemia (%) Mean haemoglobin (g/L) Anaemia (%) Severe anaemia (%)
Children aged <5 years
High-income regions 123 (120–124) 11% (7–17) 0·3% (0·0–1·1) 123 (119–125) 11% (6–20) 0·1% (0·0–0·5)
Central and eastern Europe 116 (109–122) 29% (15–47) 1·4% (0·2–5·1) 117 (111–123) 26% (13–45) 0·2% (0·0–1·1)
East and southeast Asia 118 (115–120) 29% (22–37) 0·9% (0·5–1·5) 118 (113–123) 25% (16–38) 0·2% (0·1–0·6)
Oceania 111 (102–118) 42% (23–64) 2·0% (0·2–7·7) 112 (105–120) 43% (21–65) 0·5% (0·0–2·6)
South Asia 100 (96–105) 70% (59–78) 5·9% (3·0–9·1) 106 (102–111) 58% (44–69) 2·1% (0·8–4·4)
Central Asia, Middle East, and north Africa 111 (108–114) 43% (35–53) 1·5% (0·6–3·0) 114 (110–118) 38% (25–51) 0·4% (0·1–1·2)
Central and west Africa 95 (92–98) 80% (74–84) 9·7% (7·4–12·1) 100 (99–102) 71% (67–74) 4·9% (3·8–6·2)
East Africa 96 (93–100) 74% (65–81) 10·2% (7·7–12·6) 107 (105–108) 55% (50–59) 2·5% (1·8–3·6)
Southern Africa 116 (111–119) 30% (21–42) 1·1% (0·3–2·3) 110 (105–116) 46% (31–62) 0·9% (0·3–2·4)
Andean and central Latin America and Caribbean 113 (110–116) 38% (30–46) 1·4% (0·8–2·4) 116 (113–118) 33% (28–40) 0·4% (0·2–0·7)
Southern and tropical Latin America 117 (106–124) 28% (11–55) 1·3% (0·0–6·2) 119 (112–124) 23% (10–41) 0·2% (0·0–1·1)
Globe 109 (107–111) 47% (43–51) 3·7% (2·8–4·7) 111 (110–113) 43% (38–47) 1·5% (1·1–2·2)
Non-pregnant women aged 15–49 years
High-income regions 131 (129–132) 14% (12–18) 0·6% (0·3–1·1) 130 (128–132) 16% (12–22) 0·5% (0·2–1·0)
Central and eastern Europe 129 (124–134) 23% (13–37) 0·9% (0·3–2·2) 128 (123–132) 22% (13–37) 0·5% (0·2–1·4)
East and southeast Asia 126 (123–128) 29% (22–39) 1·0% (0·6–1·7) 129 (124–133) 21% (12–36) 0·5% (0·2–1·2)
Oceania 123 (115–130) 37% (21–56) 2·8% (0·8–6·9) 126 (119–132) 28% (14–47) 1·8% (0·4–5·2)
South Asia 117 (113–121) 53% (42–64) 3·8% (2·3–5·8) 119 (115–124) 47% (33–59) 2·4% (1·0–4·6)
Central Asia, Middle East, and north Africa 123 (120–126) 38% (31–45) 2·0% (1·2–3·2) 125 (121–129) 33% (23–43) 1·0% (0·5–2·1)
Central and west Africa 118 (114–123) 52% (39–61) 2·8% (1·8–4·1) 119 (115–123) 48% (37–58) 2·2% (1·4–4·0)
East Africa 123 (120–127) 40% (33–47) 2·7% (1·8–3·8) 128 (126–131) 28% (23–34) 1·4% (1·0–1·9)
Southern Africa 124 (119–130) 33% (21–47) 2·0% (0·7–4·5) 128 (122–134) 28% (16–44) 1·2% (0·5–2·9)
Andean and central Latin America and Caribbean 126 (123–129) 30% (24–37) 1·7% (1·1–2·7) 131 (128–134) 19% (14–26) 0·7% (0·4–1·2)
Southern and tropical Latin America 129 (120–137) 22% (9–46) 1·2% (0·2–3·7) 130 (122–138) 18% (7–41) 0·7% (0·1–2·5)
Globe 125 (123–126) 33% (29–37) 1·8% (1·3–2·3) 126 (124–128) 29% (24–35) 1·1% (0·7–1·7)
Pregnant women aged 15–49 years
High-income regions 119 (116–121) 23% (18–30) 0·5% (0·1–1·1) 119 (117–122) 22% (16–29) 0·2% (0·0–0·4)
Central and eastern Europe 117 (111–124) 30% (17–47) 0·9% (0·2–2·2) 119 (113–125) 24% (14–40) 0·3% (0·1–0·9)
East and southeast Asia 115 (112–117) 34% (28–43) 1·3% (0·7–2·0) 119 (114–123) 25% (17–38) 0·4% (0·1–1·0)
Oceania 110 (104–117) 48% (31–63) 2·8% (0·8–5·9) 115 (107–124) 36% (18–59) 1·1% (0·2–3·2)
South Asia 108 (104–111) 53% (43–63) 2·9% (1·8–4·4) 108 (105–113) 52% (40–63) 1·3% (0·7–2·4)
Central Asia, Middle East, and north Africa 114 (111–117) 37% (30–46) 1·1% (0·5–2·0) 117 (113–120) 31% (22–42) 0·4% (0·1–0·8)
Central and west Africa 105 (103–109) 61% (53–66) 3·3% (2·2–4·7) 108 (105–111) 56% (46–62) 1·8% (1·1–3·2)
East Africa 111 (109–114) 46% (41–52) 2·9% (1·9–4·1) 116 (113–118) 36% (30–41) 1·2% (0·8–1·7)
Southern Africa 117 (110–124) 34% (21–51) 1·2% (0·4–2·7) 118 (111–124) 31% (20–48) 0·4% (0·2–0·9)
Andean and central Latin America and Caribbean 115 (112–118) 37% (30–44) 1·4% (0·8–2·3) 119 (116–122) 27% (21–34) 0·3% (0·2–0·6)
Southern and tropical Latin America 115 (106–125) 37% (18–60) 1·3% (0·2–3·8) 117 (108–127) 31% (13–56) 0·5% (0·1–1·7)
Globe 112 (111–113) 43% (39–47) 2·0% (1·5–2·6) 114 (112–116) 38% (34–43) 0·9% (0·6–1·3)
Numbers in parentheses are 95% credibility intervals. Appendix pp 25–30 show mean haemoglobin and anaemia prevalence by country, and appendix pp 32–222 show estimated trends over time and 
comparisons with original country data.
Table: Mean haemoglobin concentration and anaemia prevalence by region in 1995 and 2011
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source, with an average of 1·8 sources per country. At 
least one data source was available for 38 (79%) of 
48 countries in sub-Saharan Africa.
In 1995, global mean haemoglobin concentrations 
were on average just below the thresholds for mild 
anaemia in children, and just above this threshold in 
non-pregnant and pregnant women (table). 
Corresponding values in 2011 were slightly improved 
(table), with posterior probabilities that the recorded 
increases were true increases of 0·95 for children, 0·87 
for non-pregnant women, and 0·95 for pregnant women. 
Over this period, anaemia prevalence decreased by 
4–5 percentage points in the three groups (table). 
Prevalence of severe anaemia, which is associated with 
substantially worse mortality, cognitive, and functional 
outcomes than is anaemia, also decreased (table). 
Anaemia prevalences of pregnant and non-pregnant 
women were only 9–10 percentage points apart in both 
1995 and 2011 (table), even though the haemoglobin 
distribution in pregnant women was noticeably lower 
than that in non-pregnant women (ﬁ gure 2). Relatively 
modest diﬀ erences in prevalence despite noticeably 
shifted distributions happen because anaemia is deﬁ ned 
on the basis of diﬀ erent cutoﬀ  values for these women 
(ﬁ gure 2). The estimated anaemia prevalences translate 
to 273 million (95% credibility interval 242–304 million) 
children, 496 million (409–595 million) non-pregnant 
women, and 32 million (28–36 million) pregnant women 
with anaemia in 2011. Of these individuals, 10 million 
(7–14 million), 19 million (13–29 million), and 750 000 
(520 000–1 100 000), respectively, had severe anaemia.
Trends and levels varied substantially across regions 
and countries. In both 1995 and 2011, central and west 
Africa and south Asia had the lowest mean concentrations 
of haemoglobin and the highest anaemia prevalence; 
east Africa had low haemoglobin concentrations for 
children (table). Children in these three regions had 
mean haemoglobin concentrations of 100 g/L or less in 
1995, with an anaemia prevalence of at least 70%; 
prevalence of severe anaemia was almost 10% in these 
two African regions and 6% in south Asia (table). 
Between 1995 and 2011, children in these three regions 
had the largest improvements of any region (table), with 
improvements in mean haemoglobin of 3·5 g/L or more 
per decade (posterior probability ≥0·95 for all three 
regions). Nonetheless, mean concentrations of 
haemoglobin remained lower than the cutoﬀ s for 
anaemia in these regions, and anaemia prevalence 
remained at least 55% (table); however, prevalence of 
severe anaemia more than halved (table), with an overall 
shift to the right in haemoglobin distribution. Women in 
these regions had higher haemoglobin concentrations 
than children, but mean haemoglobin was less than 
Figure 2: Global distributions of haemoglobin concentration for pregnant 
and non-pregnant women in 2011
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110 g/L for pregnant women and 120 g/L for non-
pregnant women in central and west Africa and south 
Asia (table); anaemia prevalence was about 50% in non-
pregnant women or above 50% in pregnant women in 
central and west Africa and south Asia (table). These 
regions also had the countries with the lowest 
haemoglobin concentrations and highest anaemia 
prevalences, including Benin, Burkina Faso, Côte 
d’Ivoire, Ghana, Guinea, Liberia, Mali, Niger, Senegal, 
and Togo (appendix pp 25–30). The lowest estimated 
mean haemoglobin concentrations in our analysis period 
were less than 90 g/L in children in Burkina Faso in the 
1990s, with about 90% of children with anaemia and 
almost one in six children with severe anaemia (appendix 
p 59). By 2011, mean haemoglobin in Burkina Faso had 
improved to only 91 g/L (89–95) and anaemia prevalence 
in children remained more than 85% (appendix p 59). 
South Asia had the largest number of children with 
anaemia in 2011 (102 million [76–121 million]) followed 
by central and west Africa (53 million [50–55 million]; 
ﬁ gure 3). Similarly, the largest number of pregnant 
women with anaemia lived in these regions (12 million 
[9–15 million] and 6 million [5–7 million], respectively; 
ﬁ gure 3).
High-income regions, central and eastern Europe, and 
southern and tropical Latin America had the highest 
haemoglobin distributions throughout the analysis 
period. Mean haemoglobin concentrations in these 
regions were 6–13 g/L above the relevant cutoﬀ s for 
anaemia, and anaemia prevalence was generally low 
(table, ﬁ gure 4). Haemoglobin status did not change in an 
epidemiologically meaningful or statistically signiﬁ cant 
way in the regions where concentrations were initially 
high (table). Although this ﬁ nding was partly because 
these regions had the least data, absence of a major trend 
was also noted in countries with several observations over 
time, such as Japan, South Korea, and the USA (appendix 
pp 119, 172, and 214). Other regions with little 
improvement in haemoglobin included Oceania for 
children; central and west Africa, and central Asia, Middle 
East, and north Africa for non-pregnant women; and 
south Asia for pregnant women (table). Mean 
haemoglobin concentrations might have declined and 
anaemia prevalence might have increased in children in 
southern Africa (posterior probability >0·95). By contrast, 
women’s haemoglobin concentrations improved the most 
in Andean and central Latin America and Caribbean, east 
Africa, east and southeast Asia, and Oceania, irrespective 
Figure 4: Comparison of mean haemoglobin concentrations of non-pregnant women with those of pregnant women and children in 1995 and 2011
Lines show the 95% credibility interval.
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of pregnancy status (table). In most of these regions, 
improvements were more than 2 g/L per decade, and 
posterior probabilities were greater than 0·85. In 
particular, because of large improvements, women’s 
haemoglobin concentrations in east and southeast Asia in 
2011 were among the highest in the world, similar to or 
higher than those for Latin America and Caribbean or 
high-income regions (table).
The concentrations (ﬁ gure 4) and changes (appendix 
p 31) in mean haemoglobin concentrations were 
correlated between pregnant and non-pregnant women 
across regions, with mean haemoglobin concentrations 
8–15 g/L lower during pregnancy in diﬀ erent regions. 
Trends were less correlated between children and women 
(appendix p 31).
Discussion
Our results show that, by 2011, haemoglobin distributions 
in children and women had improved in some regions 
where they had been low in the 1990s, leading to a modest 
global improvement and somewhat smaller diﬀ erences 
across regions. The prevalence of severe anaemia is now 
less than 2·5% in all regions, except among children 
from central, east, and west Africa. However, no 
improvement was shown in some groups with low 
haemoglobin and high anaemia in the 1990s, including in 
non-pregnant women in central and west Africa and 
central Asia, Middle East, and north Africa, and pregnant 
women in southern Africa and south Asia. Children’s 
haemoglobin status might have deteriorated in southern 
Africa.
Global anaemia prevalence estimated by WHO with 
data from 1993 to 200518 is consistent with our estimates, 
as are the broad regional patterns (panel). Our estimated 
global anaemia prevalence of roughly 30% in non-
pregnant women in 2011 is lower than the 40% for 2007 in 
the 6th report of the UN Standing Committee on 
Nutrition (UNSCN),19 but our 95% credibility intervals for 
pregnant women (38%, 33–43) and children (43%, 38–47) 
include their estimates of 41% and 44%, respectively. 
Furthermore, the Standing Committee reported a smaller 
global decrease in anaemia prevalence than that noted in 
our study; they also labelled some countries as having a 
deteriorating change. The diﬀ erences in results stem 
from diﬀ erences in the scope of analysis, data, and 
methods. The UNSCN report did not include high-
income regions and central and eastern Europe (16% of 
the global population), which have lower prevalences of 
anaemia than the global average. We did not include 
some data sources used in the UNSCN report, either 
because we did not have access to study meta-information 
to assess representativeness, or because we assessed 
these sources as non-representative. More importantly, 
recent DHS and other surveys have shown lower, and 
generally declining, prevalences in east African 
countries—eg, Ethiopia, Malawi, Madagascar, Rwanda, 
Tanzania, and Uganda—for which our estimates and 
trends diﬀ er the most from those of the UNSCN report. 
These surveys were not available at the time of the 
UNSCN analysis, but were used in our analysis.
Low haemoglobin concentrations can be caused by 
genetic traits, such as sickle-cell anaemia and 
thalassaemia;22 inadequate bioavailability of dietary iron 
in foods that are low in iron, folate, or vitamin B12;23–26 
malaria;12,27 schistosomiasis;28 hookworm infection;29 HIV 
infection;30 and some non-communicable diseases. Some 
of these risk factors have been associated with spatial 
variation in anaemia in west Africa in a cross-sectional 
analysis.31 Previous reports had estimated that about half 
of anaemia cases worldwide are due to iron deﬁ ciency; 
however, these studies did not assess the role of iron by 
region.2 Iron supplementation increased haemoglobin 
concentrations in those with anaemia at baseline by an 
average of 10·17 g/L for pregnant women,32 8·64 g/L for 
non-pregnant women,33 and 8·0 g/L for children25 in 
randomised intervention studies. When these shifts were 
applied to the estimated haemoglobin concentrations, the 
proportion of all anaemia amenable to iron was about 
50% in non-pregnant and pregnant women and 42% in 
children. The proportions of severe anaemia amenable to 
iron were larger: more than 50% for children and non-
pregnant women, and more than 60% for pregnant 
women.
The iron-amenable share of anaemia was largest where 
fewer other causes of anaemia exist (eg, >55% in pregnant 
women and children in east and southeast Asia and 
southern and tropical Latin America, and roughly 70% in 
the same groups in high-income regions). The share was 
smallest in regions where other factors contribute to 
anaemia (eg, <45% in children and non-pregnant women 
in diﬀ erent parts of sub-Saharan Africa and south Asia); 
however, because these regions have a large absolute 
burden of anaemia, the number of people with iron-
amenable anaemia is large compared with other regions. 
The share of severe anaemia amenable to iron was even 
greater than that for anaemia, ranging from 59% to 70% 
for pregnant women and from 55% to 70% for children. 
This ﬁ nding emphasises the large burden associated with 
low iron in the most vulnerable groups—namely pregnant 
women and children. Some of the response to iron 
supplementation relates to low bioavailability of dietary 
iron, but attention should also be given to populations 
aﬀ ected by hookworm and schistosomiasis, typically rural 
tropical regions with poor sanitation facilities, especially 
in east Asia, southeast Asia, and sub-Saharan Africa.29,34
The role of malaria in haemoglobin status and anaemia 
prevalence is likely to be largest in east and west Africa; a 
systematic review reported that malaria control in 
endemic areas improved mean haemoglobin by 7·6 g/L 
in children, and reduced anaemia by 27% and severe 
anaemia by 60%.12 In our results, central and west Africa 
and east Africa—two of the regions with the lowest 
concentrations of mean haemoglobin in 2011 in 
children—contain the countries with the highest rate of 
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Plasmodium falciparum infection.35 Some of the countries 
with the lowest concentrations of mean haemoglobin (eg, 
Burkina Faso and Mali) were also those with the highest 
rate of P falciparum infection.35 However, we noted little 
within-region correlation between the proportion of the 
population at risk and mean haemoglobin, possibly 
because other determinants of haemoglobin also vary 
both between and within countries. Isolation of the 
independent causal eﬀ ects of these determinants would 
need data for various risk factors at ﬁ ne geographical 
scale.31 Sickle-cell traits and thalassaemias might have a 
more important role than does malaria in sub-Saharan 
Africa, parts of central and south Asia, and the 
Mediterranean.16,36
Isolation of the contributions of changes in the above 
factors to regional trends over time requires detailed data 
for each of these determinants; such data are rare and 
should ideally be included in future global databases. 
Furthermore, important interactions exist between iron 
and infections, which possibly makes the notion of 
independent roles irrelevant from clinical and public 
health perspectives.37 The frequency of thalassaemias and 
sickle-cell anaemia is unlikely to have changed suﬃ  ciently 
to account for trends. Reductions in malaria attributable 
to the introduction of insecticide-treated bednets38 is likely 
to have contributed to observed improvements in Africa, 
especially in children whose haemoglobin distribution 
improved in central, east, and west Africa, as might 
improved control of hookworm and schistosomiasis39 in 
sub-Saharan Africa and Asia. Improvements in 
haemoglobin concentrations in children could have been 
associated with improvements in overall nutritional and 
anthropometric status, which has improved in all regions 
except sub-Saharan Africa.14 The availability of animal 
products for human food has increased in east and 
southeast Asia, which is shown by increases in 
concentrations of serum cholesterol.40,41 Programmes for 
intermittent iron and folic acid supplementation that 
target women of reproductive age might have contributed 
to improvements in some countries, including Laos, 
Cambodia, and Vietnam.42–44 However, coverage of iron 
supplementation during pregnancy in developing 
countries remains low, because many pregnant women 
do not attend antenatal clinics or receive suﬃ  cient doses 
of supplement, or because of insuﬃ  cient emphasis on 
behavioural aspects of regular supplement use.45
Nutritional anaemia should ideally be addressed 
through dietary diversiﬁ cation and improved access to 
foods that have high iron bioavailability, including animal 
products. Other food-based approaches, such as 
fortiﬁ cation of staple foods and condiments, can also be 
used. Wheat ﬂ our fortiﬁ cation with folic acid and iron is 
mandated in more than 70 countries, but the extent of 
implementation varies.46 In addition to food-based 
programmes, daily or intermittent iron supplementation, 
alone or together with folic acid and other micronutrients, 
can be used for high-risk groups (ie, children, pregnant 
women, and women of childbearing age) to improve 
intakes in countries where they might be deﬁ cient in the 
diet and where losses might be increased—eg, where 
hookworms and schistosomiasis are prevalent. In some 
studies, iron supplementation in malaria-endemic 
settings exacerbated malarial disease and even increased 
mortality in young children.47–49 A meta-analysis of 
supplementation studies50 has led to a recommendation to 
integrate iron provision with malaria prevention and 
treatment,51,52 which can together have synergistically 
beneﬁ cial eﬀ ects on haemoglobin status. Preventive 
interventions, including insecticide-treated bednets and 
intermittent preventive treatment, also improve 
haemoglobin concentrations of children and pregnant 
women living in malaria-endemic areas,1,12,27 as do 
improved water and sanitation and deworming in regions 
where hookworms are common.
The strengths of our study are our extensive data search 
and rigorous criteria for inclusion of sources; consistent 
analysis for children and women, and by pregnancy 
status; estimation of trends by country and region; 
estimation of the full population distributions of 
haemoglobin, which is consistent with epidemiological 
Panel: Research in context
Systematic review
We searched PubMed with search terms detailed in appendix pp 1–3 for studies published 
after Jan 1, 1990. In addition to indexed articles, many such comparisons are in national 
and international agency reports, which we also identiﬁ ed and accessed through requests 
to national and international organisations.
Some studies have reported anaemia prevalence in individual or several countries,19 with 
some also reporting change across repeated surveys.20,21 The Global Burden of Disease 
Study 1990 quantiﬁ ed the global and regional prevalences of anaemia, with the estimates 
updated periodically by WHO.2,18 These prevalence estimates have been extended to the 
country level with use of a regression model.18 These reports did not analyse the whole 
distribution of haemoglobin nor did they estimate severe anaemia, even though various 
cognitive and health eﬀ ects take place along a continuum of haemoglobin 
concentrations, with some being greatest in the severe tail of the distribution. 
Furthermore, the only analysis of how anaemia has changed simply averaged the available 
surveys in 5 year intervals, but did not formally analyse trends.19
Interpretation
Our study advances the international reporting and comparison of children’s and women’s 
haemoglobin concentrations and anaemia prevalences. We estimated the full population 
distributions of haemoglobin, for children and women, and by pregnancy status, which 
allowed for coherent and consistent estimation of mean haemoglobin and of the 
prevalences of total and severe anaemia between 1995 and 2011 in all countries. In the past 
few decades, central and west Africa and south Asia have consistently had the lowest 
concentrations of mean haemoglobin and the highest anaemia prevalences of any region, 
with east Africa also having low haemoglobin concentrations for children. Haemoglobin 
distributions in children and women improved in some regions where they had been low in 
the 1990s, leading to a modest global improvement and somewhat smaller diﬀ erences 
across regions. However, some places with low haemoglobin and high anaemia in the 
1990s had no or little improvement. Further actions to improve haemoglobin are needed 
to improve women’s and children’s health and achieve global targets for reducing anaemia.
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evidence about the harms of low haemoglobin 
concentrations; and systematic estimation and reporting 
of uncertainty. The main limitation of our analysis is that, 
despite the extensive data search and access, fewer data 
were available for anaemia and haemoglobin than for 
other nutritional and physiological indicators, such as 
anthropometric status and blood pressure in women and 
children,14,17,53 especially in the early years of our analysis 
period. This restriction might have arisen from a scarcity 
of low-cost portable instruments for ﬁ eld measurement 
of haemoglobin concentrations. As a result, the estimates 
might not capture the full variation across countries and 
regions, and could tend to shrink towards global means 
when data are sparse. This outcome might have especially 
aﬀ ected the estimates in high-income and upper-middle-
income countries, where anaemia prevalence is low and 
typically addressed in a clinical setting. Because our 
analysis unit was age-country-year, we could use only 
covariates for which we had data for every country-year, 
and could not incorporate potentially important predictors 
of haemoglobin with scarce data, especially dietary iron 
and iron supplementation. Similarly, although we 
adjusted haemoglobin for altitude and used data adjusted 
for smoking when available, we could not do so for 
inﬂ ammation because most surveys did not obtain 
information about inﬂ ammation and because no standard 
adjustment exists. The adverse eﬀ ects of low haemoglobin 
are largest in pregnant women and young children, but 
there are also eﬀ ects in other groups, including 
adolescents, elderly people, and men.18 We did not include 
these groups in our analyses because substantially fewer 
representative data are available; these other groups could 
account for 45% of all anaemia cases. Finally, our study 
focused on national-level patterns of haemoglobin and 
anaemia; it would be ideal to have information about 
nutritional indicators at the subnational level—eg, by 
rural versus urban place of residence, province or state,54 
or socioeconomic status.55 
Reduction of anaemia is an important component of 
women’s and children’s health. Despite the modest 
improvements shown, haemoglobin concentrations 
remain low and anaemia prevalence remains high in the 
poorest regions of the world, presenting an obstacle to 
reducing maternal and neonatal mortality and to healthy 
early childhood development. If present trends are 
maintained, the probability of halving anaemia from 2011 
levels by 2025 in women of reproductive age is less than 
25% in all regions individually, and negligible at the 
global level. Further improvements are likely to need a 
combination of programmes that address the parasitic 
disease and nutritional determinants of low haemoglobin 
and those that scale up supplementation, especially 
during pregnancy. Beyond mortality outcomes, the 
cognitive beneﬁ ts of increased haemoglobin will lead to 
improved school performance and work productivity, and 
contribute to better health and economic outcomes 
throughout the life course.1,3,56
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